复方活血汤对再生障碍性贫血小鼠骨髓造血细胞粘附分子及细胞周期蛋白表达作用  被引量:43

Effect of Composite Blood Activating Decoction on Expression of Adherent Molecule and Cyclin in Bone Marrow Hematopoietic Cells in Mice of Immune Induced Aplastic Anemia

在线阅读下载全文

作  者:孙汉英[1] 董凌莉[1] 刘文励[1] 陶德定[1] 徐慧珍[1] 

机构地区:[1]同济医科大学附属同济医院

出  处:《中国中西医结合杂志》1999年第2期100-102,共3页Chinese Journal of Integrated Traditional and Western Medicine

基  金:国家自然科学基金

摘  要:目的:探讨复方活血汤(简称中药)对免疫诱导的再生障碍性贫血(再障)小鼠骨髓造血细胞粘附分子及细胞周期蛋白表达的作用。方法:建立免疫诱导的再障小鼠模型,喂饲100%复方活血汤每次02ml,每日2次,第13日用流式细胞仪检测小鼠骨髓单个核细胞β1整合素家族(CD49d/CD29,α4β1;又称VeryLateAntigens,VLA家族)及细胞周期蛋白D2的表达水平。结果:中药组CD49d表达明显高于再障组(P<005),且与正常组无明显差异;中药组细胞周期蛋白D2表达明显高于再障组(P<001);而其G0+G1期细胞数显著低于再障组(P<001)。结论:复方活血汤能增强免疫再障小鼠骨髓造血细胞粘附分子CD49d和细胞周期蛋白D2的表达,促进造血细胞的增生。Objective: To study the effect of composite blood activating decoction (CBAD) on expression of adherent molecule CD 49 d and cyclin D 2 in bone marrow hematopoietic cells in experimental immune mediated aplastic anemia (AA) mice. Methods: After the model of AA was established, the animals were fed with 0.2ml of 100% CBAD, twice a day for 12 days. Te CD 49 d and cyclin D 2 expression level of bone marrow hematopoietic cells in model mice were measured by flow cytometor analysis system at the 13th day of experiment. Results: CD 49 d expression level in CBAD group was significantly higher than that in the AA group (P<0 05), and was similar to that in the normal group (P>0 05). The expression of cyclin D 2 in CBAD group was significantly higher than that in the AA group (P<0 01), but the cell count of G 0+G 1 phase was significantly lower in the CBAD group, as compared with the AA group, P<0 01. Conclusion: CBAD can increase the expression of adherent molecule CD 49 d and cyclin D 2 in bone marrow hematopoietic cells, and promote the growth of hematopoietic cells.

关 键 词:复方活血汤 再生障碍性贫血 骨髓造血细胞 

分 类 号:R259.565[医药卫生—中西医结合]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象